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Abstract
Background: Genome editing by CRISPR-Cas9 technology allows large-scale screening of gene essentiality in
cancer. A confounding factor when interpreting CRISPR-Cas9 screens is the high false-positive rate in detecting
essential genes within copy number amplified regions of the genome. We have developed the computational tool
CRISPRcleanR which is capable of identifying and correcting gene-independent responses to CRISPR-Cas9 targeting.
CRISPRcleanR uses an unsupervised approach based on the segmentation of single-guide RNA fold change values
across the genome, without making any assumption about the copy number status of the targeted genes.
Results: Applying our method to existing and newly generated genome-wide essentiality profiles from 15 cancer
cell lines, we demonstrate that CRISPRcleanR reduces false positives when calling essential genes, correcting biases
within and outside of amplified regions, while maintaining true positive rates. Established cancer dependencies and
essentiality signals of amplified cancer driver genes are detectable post-correction. CRISPRcleanR reports sgRNA fold
changes and normalised read counts, is therefore compatible with downstream analysis tools, and works with multiple
sgRNA libraries.
Conclusions: CRISPRcleanR is a versatile open-source tool for the analysis of CRISPR-Cas9 knockout screens to identify
essential genes.
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Background
CRISPR-Cas9-based genome editing techniques are trans-
forming the landscape of genetic studies [1, 2]. The high
efficiency and specificity of the CRISPR-Cas9 system to
mutagenise genes through the introduction of DNA
double strand breaks (DSB), either at the level of individ-
ual genes or at genome-wide scale, enables the systematic
investigation of loss-of-function phenotypes.
We and others have developed genome-wide pooled
CRISPR knock-out (CRISPR-KO) screening strategies
[3–5]. A prominent application of CRISPR-KO screens
is the systematic identification of genes that are essential
for cancer cell fitness to identify strategies for the devel-
opment of novel targeted therapies. These studies typic-
ally introduce Cas9 endonuclease into cells, followed by
or alongside the introduction of a library of pooled
sgRNAs targeting the genome. The library usually
contains multiple single guide RNA (sgRNA) targeting
each gene to facilitate a robust identification of essential
genes. Analysis strategies compare the abundance of
sgRNAs between control and test samples to determine
which sgRNAs are differentially represented, thus target-
ing a gene that is potentially essential to the fitness of
the cancer cells. Several groups have performed these
types of screens to identify novel drug targets [6, 7]. A
recent landmark study has reported gene essentialities in
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342 cancer cell lines [8]. This will empower association
studies between gene essentialities and genomic/tran-
scriptomic features to develop biomarkers for patient
stratification.
One drawback of the CRISPR-KO screening system is
caused by its mode of action, namely DSB induction. DSBs
trigger a DNA damage response which can cause cell cycle
arrest and in some cases cell death [9–11]. This is prob-
lematic when performing whole-genome CRISPR-KO
screens in cancer cells because of frequent copy number
(CN) alterations in their genome, resulting in widespread
Cas9 induced DNA damage. Consequently, DSBs at genes
in amplified regions result in depletion of these genes in a
pooled CRISPR-KO screen regardless of their essentiality,
and thus they are erroneously called as fitness genes. This
can result in a high false-positive rate and correcting for
this CN-associated effect is crucial for the interpretation
of CRISPR-KO screening results. Solutions proposed thus
far encompass scanning the dataset for biased regions and
their removal from downstream analysis [12], resulting in
the exclusion of potentially biologically relevant genes
residing in CN-amplified regions, or to apply a piecewise
linear model to infer true gene dependencies based on CN
profiles across large panels of cell lines [8].
During the analysis of CRISPR-KO data we identified a
number of instances for which existing approaches for
correcting bias in CRISPR-KO data were unsuitable or
hampered further downstream analyses. To address this,
we developed CRISPRcleanR, a computational approach
implemented in open-source R and a Python packages,
which identifies biased genomic regions from CRISPR-KO
screens in an unsupervised manner and provides both
corrected read count and log fold change (logFC) values
of individual sgRNAs in such regions. Our method re-
duces false positive calls while keeping the true positive
rate of known essential genes largely unchanged, and
allows the detection of essential genes even within focally
amplified regions.
Results
Gene-independent responses in CRISPR-KO screens
We performed genome-wide CRISPR-KO screens on 15
human cancer cell lines (hereafter called ‘Project Score’),
which are a subset of the Genomics of Drug Sensitivity in
Cancer (GDSC) collection (Additional file 1: Table S1)
[13, 14]. This involved six tumour types with different
mutational processes, including high frequency of
single-nucleotide variants (large intestine, lung, and mel-
anoma) and CN variation (breast and ovary). We used the
Sanger Institute CRISPR library (version 1.0) targeting
18,010 genes (90,709 sgRNAs; ~ 5 sgRNAs per gene) [6].
The screens showed high consistency between technical
replicates in each cell line (median average correlation for
sgRNA counts = 0.83) and readily discriminated between
pre-defined fitness essential (FE) and non-essential genes
(median area under the Receiver Operating Characteristic
curve (AUROC) = 0.92) (Additional file 2: Figure S1) [15].
Additionally, a high true positive rate (TPR, or recall) was
observed for known essential genes assembled from the
Molecular Signature Database (MsigDB) [16] and from
literature [17] (median TPR across gene sets and cell lines
= 85% at 5% FDR).
When comparing CRISPR data and CN profiles for
each line, we confirmed a large negative effect for logFCs
of sgRNAs targeting genes in CN-amplified regions,
particularly with CN ≥ 8 (Additional file 2: Figure S2 and
Additional file 1: Table S2). Notably, sgRNA targeting
CN-amplified (CN ≥ 8) non-expressed genes (FPKM <
0.05) were significantly more depleted in six cell lines
than the rest of the sgRNA in the whole library. For
three cell lines (HT55, EPLC-272H, and MDA-MB-415),
the negative effect on logFC of sgRNA in CN-amplified
regions was comparable or greater than for FE genes
(Additional file 2: Figure S3 and Additional file 1: Table
S2). Collectively, using independent data, our analysis
confirms the systematic negative bias on sgRNA logFC
values in particular regions of the genome, which are
enriched for CN amplifications.
Variable effect of amplification on responses to CRISPR-
Cas9 targeting
To gain greater insight into CN-associated biases, we per-
formed a detailed analysis of the relationship between
sgRNA logFC values and CN at the level of individual CN
segments (Fig. 1a and Additional file 2: Figure S4). For
some cell lines, the negative bias on average logFC values
within segments was positively correlated with CN values
(EPLC-272H, NCI-H520, OVCAR-8, TOV-21G and
SW48). In other cell lines the bias effect on average logFC
was not observed (MDA-MB-436), plateaued (NCI-H2170),
or fluctuated as CN varied (MDA-MB-453, HT55 and
HuP-T3). These effects were preserved when only consider-
ing sgRNA targeting non-expressed genes (Fig. 1b and
Additional file 2: Figure S4), demonstrating that the nega-
tive logFCs are most likely independent of true gene essen-
tiality. In addition, we observed a wide range of average
logFC values for segments of a given CN (Fig. 1a, b), and
this is often larger than the variation between segments of
different CN, indicating that CN alone does not capture all
of the observed bias variance.
Furthermore, although in the majority of instances CN
segments matched segments of equal sgRNA logFCs
(Fig. 1c), we identified several CN segments with discon-
tinuous logFC patterns (Fig. 1d). Additionally, regions of
consistently depleted sgRNAs were identified also in
diploid regions of the genome. For example, the cell line
CL-40 harbours two copies of chromosome 16, but sev-
eral contiguous genes (of which many are not expressed)
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in region 16q23 exhibited a negative logFC across target-
ing guides (Fig. 1e).
Our results indicate that biases observed in CRISPR-KO
screens are often associated with CN alterations but are
heterogeneous, with poorly understood variation between
segments of differing CN, and variation within segments of
the same CN. Taken together, these results highlights the
value of an unsupervised approach, not dependent on CN
alone, to correct for biased regions in CRISPR-KO data.
CRISPRcleanR corrects bias in CRISPR-Cas9 datasets
In order to detect biased regions in an unsupervised
manner and correct corresponding sgRNA logFCs in
CRISPR-KO screening data, we developed CRISPR-
cleanR, a computational approach implemented in
open-source R and Python packages. CRISPRcleanR
applies a circular binary segmentation algorithm, origin-
ally developed for array-based comparative genomic
hybridization assay [18, 19], directly to the genome-wide
patterns of sgRNA logFCs across individual chromo-
somes in a cell line. It then detects genomic segments
containing multiple sgRNAs with sufficiently equal
logFCs. If these segments contain sgRNAs targeting a
minimum number of distinct genes then the sgRNA in
the segment are most likely responding to CRISPR-Cas9
targeting in a gene-independent manner, and logFCs
values are corrected via mean-Centering. Median-based
centering can also be applied for experimentally variable
data or in the presence of many outliers.
CRISPRcleanR embeds functions from the DNAcopy R
package [20] allowing users to customise their argu-
ments. Furthermore, it has several features that make it
statistically robust, versatile and practical for down-
stream applications: (i) it works in an unsupervised man-
ner, requiring no chromosomal CN information nor a
priori defined sets of essential genes; (ii) it implements a
logFC correction, making depletion scores for all genes
usable in follow up analyses; (iii) it examines logFC at
the sgRNA level to gain resolution and to account for
different levels of sgRNA on-target efficiency, and en-
ables the subsequent use of algorithms to call gene de-
pletion significance that require input data at the sgRNA
level (e.g. BAGEL [21]); (iv) by applying an inverse trans-
formation to corrected sgRNA logFCs, it computes cor-
rected sgRNA counts, which are required as input for
commonly used mean-variance modeling approaches,
such as MAGeCK [22], to call gene depletion/enrich-
ment significance; (v) lastly, CRISPRcleanR corrects
logFC values using data from an individual cell line and
with invariant performances, unlike other computational
correction approaches whose performances depend on
the number of analysed cell lines [8]; as a consequence,
EDC
B
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Fig. 1 Heterogeneous gene-independent responses to CRISPR-Cas9 targeting. a Average logFC values of sgRNA within segments of equal CN
(excluding FE and histones) for three cell lines. Each circle represents a CN segment of the indicated copy number. Asterisks mark the CN at
which a significance difference (Welchs t-test, p < 0.05) is initially (starting point) and continuously (critical point) observed compared to logFC
values at CN = 2. Box-plots show the median, inter-quartile ranges and 95% confidence intervals. b Same as for A but considering only non-
expressed genes (FPKM < 0.05). (c,d,e) Segments of equal gene copy number and segments of equal sgRNA logFCs for selected chromosomes in
three cell lines
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CRISPRcleanR is suitable for the analysis of data from
both small- and large-scale CRISPR-KO studies.
When applied to Project Score data, CRISPRcleanR
effectively corrected the bias in sgRNA logFCs over a wide
range of chromosomal segments with variable CN alter-
ations. Furthermore, this included detection and correc-
tion of different level of biases in sgRNA logFCs within an
individual segment of equal CN (Fig. 2a, b). An immediate
result of the application of CRISPRcleanR to our data was
that biases in particularly high CN regions were strongly
attenuated over all the cell lines (Fig. 2c).
Overall, CRISPRcleanR reduced the recall of sgRNAs
targeting CN-amplified regions, including sgRNAs
targeting CN-amplified non-expressed genes, towards
expectation when classifying the whole library of
sgRNAs based on their logFCs (Fig. 2d). The correction
was also consistently observed at the gene level (average
logFCs of targeting sgRNAs) across all screened cell lines
at a fixed 5% FDR, with a median reduction in recall
equal to 72% and 88%, respectively for CN-amplified
and CN-amplified non-expressed genes (Fig. 2e and
Additional file 1: Table S3). This reduction was also
A B
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Fig. 2 Unsupervised detection of segments of equal sgRNA logFCs and their correction. a and b Example segments of equal gene copy number
and equal sgRNA logFC values detected and corrected by CRISPRcleanR in two cell lines. c logFC values of sgRNAs of the entire library for all cell
lines grouped according to the copy number of their targeted gene before (left) and after (right) CRISPRcleanR correction. Box-plots show the
median, inter-quartile ranges and 95% confidence intervals. d Recall curves of sgRNA when classified as targeting amplified genes, amplified
non-expressed genes, FE genes, and non-essential genes before and after CRISPRcleanR correction, for an example cell line (EPLC−272H). e
Assessment of CRISPRcleanR correction comparing Recall at 5% FDR (top row) or area under the Recall curve (AURC, bottom row) of genes
in six predefined gene sets based on their uncorrected or corrected logFCs (averaged across targeting sgRNAs)
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observed at the level of the area under the overall recall
curves (AURCs), thus independent of a fixed depletion
significance threshold. Specifically, we observed the
median AURCs across all cell lines shifting from 0.74 to
0.51 (p = 0.02, Welch’s two sample t-test) and from 0.7
to 0.5 (p = 0.01), respectively, for CN-amplified and
CN-amplified non-expressed genes (Fig. 2e and
Additional file 1: Table S3). The reduction in AURC was
independent of whether amplified genes in cell lines
were identified using CN data from the GDSC or the
cancer cell line encyclopedia (CCLE). In contrast, for the
MsigDB known essential genes and the FE genes, the
reduction was negligible at less than 2%, with median
AURCs preserved at ≥0.82.
Excluding from the essentiality profiles the sgRNAs
targeting a priori known essential genes (taken from
MSigDB) before CRISPRcleanR correction yielded very
similar results as when imposing the constraint that, for
a segment to be corrected, it must contain sgRNA tar-
geting n = 3 different genes (Additional file 2: Figure S5).
This was determined by performing several correction
attempts varying n and considering or not FE and other
MSigDB essential genes. Thus, CRISPRcleanR can be
used in a completely unsupervised setting, without
making any assumption on gene essentiality.
CRISPRcleanR is effective using multiple sgRNA libraries
To investigate the versatility of CRISPRcleanR we assessed
its performance across different libraries of sgRNAs. For
the purpose of comparability we initially used our previ-
ously published dataset derived from screening the HT-29
cell line with the Brunello [23] and Whitehead [12] librar-
ies, using the same lentiviral vector as our library [24]. Of
note, despite all three libraries targeting 17,646 overlap-
ping genes, fewer than 5% of the 19-mer gRNA in the
libraries are overlapping in sequence. A similar reductions
in recall for CN-amplified genes (mean = 40 ± 2.7%), CN
amplified non-expressed genes (45 ± 5.7%), fitness
essential genes (2 ± 0.47%), and non-essential genes
(mean = − 3.8 ± 1.81%) was observed across all three
libraries (Fig. 3a, b). As a specific example, all three
libraries showed matching patterns of biased logFCs in
the same CN-amplified genomic region spanning the
proto-oncogene MYC on chromosome 8 (Fig. 3c).
CRISPRcleanR corrected the sgRNA logFC values for this
bias in all three libraries.
To further evaluate the compatibility of CRISPRcleanR
with different sgRNA libraries, we tested it on an inde-
pendent dataset of 342 cell lines using the Avana library
from Project Achilles [8] (Additional file 2: Figure S6).
We observed a reduction of false positive hits (average
recall at 5% FDR) for CN-amplified genes after correc-
tion from 0.10 to 0.04 (p = 6.23 × 10− 29) based on GIS-
TIC [25] copy number scores from the CCLE, from 0.27
to 0.08 (p = 1.64 × 10− 8) based on PicNic [26] copy
number scores from the GDSC [13], and from 0.03 to
0.001 (p = 10− 4) for non-expressed genes which are
CN-amplified according to either GISTIC or PicNic
scores. Additionally, true positive rates for known essen-
tial genes were slightly increased (average recall at 5%
FDR) for a priori known essential genes from MSigDB
[16] from 0.74 to 0.76 (p = 0.06), and significantly in-
creased for essential genes from [15] from 0.59 to 0.63
(p = 8 × 10− 4, Additional file 2: Figure S6). The recall
increment for known essential genes was greatest for
lower quality CRISPR-KO data, suggesting that CRISPR-
cleanR contributes to a signal improvement in noisy or
low quality data (Additional file 2: Figure S7). Taken to-
gether, these results show that CRISPRcleanR is suitable
for correcting bias in CRISPR-KO screening datasets
generated with a variety of different sgRNA libraries.
CRISPRcleanR preserves cell line essentiality profiles
We next determined whether the correction performed by
CRISPRcleanR alters the overall essentiality profile of a
given cell line. For Project Score data, we checked the pos-
ition of sets of top-depleted sgRNAs from uncorrected
logFCs along the profiles of corrected sgRNA logFCs by
means of precision/recall analysis (Fig. 4a, b). We ob-
served a median area under the precision/recall curve
(AUPRC) of 0.92 (min = 0.81 for HCC-15, max = 0.96 for
MDA-MB-436) for the top 50 depleted sgRNA, and a me-
dian AUPRC of 0.96 for the top 2500 depleted sgRNA
(min = 0.88 for HCC-15, max = 0.98 for MDA-MB-453).
Considering that an experiment typically yields ~ 6000
sgRNAs called as significantly depleted with our library,
this indicates that the CRISPRcleanR correction, while
reducing false-positive rates, does not have an unwanted
impact on the overall essentiality profile of a cell line.
To further assess the impact of CRISPRcleanR on gene
essentiality profiles, we compared all genes with a signifi-
cant gain or loss-of-fitness effect before and after CRISPR-
cleanR correction as this is the key phenotype measured
in CRISPR-KO screens (Additional file 2: Figure S8). For
Project Score data, we found CRISPRcleanR impacted on
the significant loss/gain-of-fitness effect for a median of
1.98% of all screened genes. This included a median of
24.69% genes significantly detected as exerting an effect
on cellular fitness (gain- or loss-of-fitness) and a median
of 17.02% of loss-of-fitness genes. The vast majority (88%)
of these attenuated loss-of-fitness genes were composed
of putatively false positive hits, involving genes which are
not expressed (FPKM < 0.05), located in CN-amplified
segments, prior known non-essential, or genes with a
weak loss-of-fitness effect when compared to the whole
set of genes called as loss-of-fitness in the uncorrected
data (average logFC over the 4th quartile). For a very small
number of genes (median 0.02% of genes, n = 28 unique
Iorio et al. BMC Genomics  (2018) 19:604 Page 5 of 16
genes total) the post-correction fitness effect was opposite
to that observed prior to the correction. A very similar
effect on significant genes following CRISPRcleanR cor-
rection was observed for the Project Achilles data (Add-
itional file 2: Figure S8). Thus, CRISPRcleanR preserves
the overall essentiality profile present in a cell line and
alters the significant fitness effects observed in the uncor-
rected data for only a minority of genes. Where correction
occurs, the majority of instances involve likely putative
false positive genes.
A
B C
Fig. 3 CRISPRcleanR is effective with multiple different sgRNA libraries. a Recall curves for three sgRNA libraries when classifying sgRNAs targeting
amplified genes, amplified non-expressed genes, FE genes, and non-essential genes using sgRNA logFCs before (first row of plots) and after (second
row of plots) CRISPRcleanR correction. b Variation of the area under the recall curve for sgRNAs targeting genes in six predefined sets, based on their
uncorrected/corrected logFCs, across the three different libraries (one circle per library). c Segments within chromosome 8 of equal gene copy number
juxtaposed to segments of equal sgRNA logFCs before and after CRISPRcleanR in HT-29 cells screened with three different sgRNA libraries. The position
of MYC is shown with a blue line
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CRISPRcleanR corrects sgRNA counts to enable mean-
variance modeling
MAGeCK is a widely used computational tool to call gene
depletion or enrichment in CRISPR-KO screens and is
based on mean-variance modelling of median-ratio nor-
malised sgRNA read-counts [22]. To make CRISPRcleanR
compatible with mean-variance modeling approaches
such as MAGeCK, we designed an inverse transformation
to derive corrected sgRNA treatment counts from
CRISPRcleanR corrected sgRNA logFC values. To bench-
mark our transformation, we compared results obtained
from executing MAGeCK using normalised uncorrected
and CRISPRcleanR corrected sgRNA counts by means of
recall estimation when classifying predefined gene sets.
The inverse transformation had an effect on both the
mean and variance of the sgRNA counts, with the greatest
impact on sgRNAs targeting genes in CN-amplified
regions, whose value was consistently shifted toward the
corresponding value in the plasmid/control condition
(Fig. 5a, b). Furthermore, we observed a strong reduction
in recall when classifying sgRNAs targeting genes in
biased regions (PicNic scores ≥8 or GISTIC ≥2), when
considering as positive predictions the sgRNAs called
significantly depleted by MAGeCK. The median reduction
was 75% for CN-amplified genes and 80% for
CN-amplified non-expressed genes at a 10% FDR, and
72% and 100% reductions at a 5% FDR (Fig. 5c and Add-
itional file 1: Table S4). In contrast, the effect on the recall
of FE and non-essential genes was negligible (median =
2.9% reduction) (Fig. 5c). Thus, the reverse transformation
post-correction enables the use of mean-variance model-
ling approaches such as MAGeCK for downstream calling
of significant depletion or enrichment of genes.
Robust detection of cancer dependencies following
CRISPRcleanR
Since a major application of CRISPR-KO screens is the
accurate identification of genes essential for cellular fitness
in defined molecular settings, we investigated the ability of
CRISPRcleanR to preserve the detection of expected cancer
gene dependencies in individual cell lines. To perform a
systematic analysis, we used CRISPRcleanR corrected
sgRNA counts and a set of 64 cancer driver genes [27]
which are modified by somatic mutation or CN amplifica-
tion. We considered CN amplifications at the segment level
(from [13]), thus including multiple genes in a segment.
Project Score cell lines included a total of 57 potential
dependencies, involving a total of 29 cancer driver genes
(9 mutated and 20 genes in amplified CN segments). Of
these, we detected 21 dependencies prior to CRISPR-
cleanR correction (MAGeCK FDR < 10%), and 16 of them
(76%) were preserved following CRISPRcleanR correction
(Additional file 2: Figure S9 and Additional file 1: Table
S5). Examples included SW48 carrying the EGFRg719s
mutation associated with depletion of EGFR targeting
sgRNA, and MDA-MB-453 carrying the PIK3CAh1047r
mutation associated with depletion of PIK3CA targeting
sgRNA (Fig. 6a).
CRISPRcleanR preserved the ability to selectively detect
cancer dependencies involving amplified cancer driver
genes. For example, MYC is amplified in the cell line
HT-29 and sgRNAs targeting MYC, as well as flanking
genes, are reported as significantly depleted when using
uncorrected logFCs (Fig. 6b). The logFC depletion is
greater for MYC compared to other genes in this region.
Following CRISPRcleanR correction, the sgRNAs target-
ing MYC remained significantly depleted, whereas those
targeting the co-amplified flanking genes were no longer
significant. A similar essentiality was selectively preserved
post-CRISPRcleanR correction in an amplified region of
chromosome 16 that contains ERBB2 in the NCI-H2170
cell line (Fig. 6c). Two of the dependencies attenuated
post correction involved co-amplification of two driver
genes; CDK12 co-amplified with ERBB2 in NCI-H2170
and CTTN co-amplified with CCND1 in MBA-MB-415
were no longer significant post correction. Similar results
were found using the Project Achilles data with an overall
retention rate of 80% (179 of 233) of dependencies post
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Fig. 4 CRISPRcleanR retains overall essentiality profiles. a Example precision/recall curves in HuP-T3 cells for the indicated number of top depleted
sgRNAs after CRISPRcleanR correction, classified based on their un-corrected sgRNAs logFC rank position. b Area under the precision/recall curves
defined as for A for all cell lines. Box-plots show the median, inter-quartile ranges and 95% confidence intervals
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CRISPRcleanR correction (Additional file 2: Figure S9 and
Additional file 1: Table S5). Of the attenuated dependen-
cies, 41% (n = 44) involved genes co-amplified with
another driver gene. In addition, we observed in both
datasets a trend of increased significance (as measured by
FDR) of detected dependencies post-correction. Overall,
these results demonstrate that CRISPRcleanR allows for
the accurate detection of cancer driver gene dependencies
in CRISPR-KO datasets, including cancer genes residing
within CN-amplified regions.
Code availability and overview
CRISPRcleanR is implemented as an R [28] package and
as an interactive Python package with full documenta-
tion, tutorials, built in datasets to reproduce the results
in this manuscript, and is publically available (R package:
https://github.com/francescojm/CRISPRcleanR and Py-
thon package: https://github.com/cancerit/pyCRISPR-
cleanR). The Python implementation is dockerized
making it platform independent and usable in cloud
environments (https://dockstore.org/containers/quay.io/
wtsicgp/dockstore-pycrisprcleanr). CRISPRcleanR in-
cludes core functions for processing raw sgRNA count
files for generating corrected sgRNA logFC values and
corrected sgRNA counts for downstream analyses.
CRISPRcleanR also includes functions to measure and
visualise the extent and effect of the performed correc-
tion, the ability to detect CN-amplified non-expressed
genes (which can be used as positive controls), and
classification performances for a priori known sets of es-
sential/non-essential genes pre- and post-correction.
Discussion
In this study, we report CRISPRcleanR, a computational
tool that detects genomic segments of gene-independent
responses to CRISPR-KO in an unsupervised manner,
and applies a segment-by-segment correction at the
sgRNA-level for both fold-changes and read counts. The
correction substantially reduces false-positive calls
without altering true essentiality profiles and preserves
known cancer gene dependencies within and outside of
biased segments. CRISPRcleanR works on multiple
genome-wide sgRNA libraries, and resulting corrected
sgRNA logFC and read counts are compatible with
downstream analyses performed by methods such as
BAGEL or MAGeCK to statistically assess screen hits.
CRISPRcleanR works efficiently irrespective of the sam-
ple size of the analysed dataset, even in single sample
experiments.
Our motivation for developing CRISPRcleanR came
from the observation that biases in gene essentialities
observed in CRISPR-KO screens did not always show a
linear correlation to their CN status, although biased
segments are frequently associated with CN alteration.
Additionally, in most of the cell lines analysed, variation in
the mean logFCs of segments with the same CN were
often greater than those between segments with different
CN. Some cell lines showed greater bias in segments with
lower CN. We even identified multiple instances of dis-
continuous bias on sgRNA logFCs within a particular CN
segment, and biased responses within segments that are
not CN-amplified. These observations argue for the devel-
opment of methods such as CRISPRcleanR, which are in-
dependent of CN values for the analysis of CRISPR-KO
screening data, and indicate that biased responses are not
solely due to the amount of DNA damage and may also
be caused by additional factors, such as local genomic
structural variation (as recently reported in [29]).
CRISPRcleanR detects biased segments using
sgRNA-level logFC in an unsupervised manner, eliminat-
ing the requirement for cell line CN information. This
simplifies the analysis and is advantageous when reliable
CN information is not available for a cell line; for
example, when using a newly derived cancer cell model.
In addition, cancer genomes are dynamic and continu-
ously evolving, causing genetic variation between differ-
ent clones of the same cell line. Genetic drift may occur
during prolonged in vitro cell culture, due to different
growth conditions (e.G. media composition), or in
response to selective pressure (e.g drug treatment) and
genetic manipulation (e.g. gene-editing). Thus, the gen-
omic heterogeneity of cancer cells, even within clones of
the same cell line, may confound CN-based correction
methods when relying on pre-existing CN data, and
negatively impact identification of gene essentialities.
Furthermore, the performance of different copy number
calling algorithms is variable and depends on the under-
lying genomic data available, and as a result this can be
a further confounding factor when using CN-based cor-
rection methods. CRISPRcleanR overcomes these limita-
tions by effectively correcting for biases in CRISPR-KO
screens without requiring additional information about
(See figure on previous page.)
Fig. 5 CRISPRcleanR corrected sgRNA counts and downstream analysis with MAGeCK. a and b Normalised counts of sgRNAs of the transfected
libraries versus the control plasmid for FE and non-essential genes (first two rows of plots), CN amplified genes (third row) and CN non-expressed
genes (fourth row), for two example cell lines before (first and third column) and after (second and fourth column) CRISPRcleanR correction.
Essentialities for CN-amplified cancer driver genes such as MYC, ERBB2 and CCND1 are retained post correction. For the sake of readability only
genes with at least 10 copies have been highlighted. c Comparison of recall using MAGeCK for sgRNAs targeting genes in six predefined gene
sets when using as input CRISPRcleanR uncorrected and corrected sgRNAs counts
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the cell models screened, and without making assump-
tions about the underlying cause of bias.
Conclusion
CRISPRcleanR is a flexible tool implemented as R and
Python packages to correct gene-independent bias found
in whole-genome CRISPR-KO screens in an unsupervised
manner at a single sample level. CRISPRcleanR facilitates
the analysis of CRISPR-KO screens in cancer cells to iden-
tify essential genes.
Methods
Plasmids, cell lines and reagents
Cells were maintained in culture media as indicated in
Additional file 1: Table S1 in a 5% CO2 humidified incuba-
tor at 37 °C. The plasmids used in this study were from
the mutagenesis toolkit described in [6] and are available
through Addgene (Cas9–68,343; CRISPR sgRNA library -
67,989). Plasmids were packaged using the Virapower
(Invitrogen) system as per manufacturer’s instructions.
Genome-wide mutant library and screen
Cells were first transduced with lentivirus carrying Cas9 in
T75 flasks at ~ 80% confluence in the presence of poly-
brene (8 μg/ml). The following day, lentiviral containing
medium was replaced with complete medium. Blasticidin
selection was started on day 4 post transduction at a
concentration determined from a titration in the parental
cell line. Cas9 activity was assessed following selection
using the Cas9 functional assay as described in [6] and a
cut-off of 80% activity was applied (median = 89% activity
across all cell lines). Cas9-expressing cells were main-
tained in blasticidin prior to transduction with the sgRNA
library. Transduction with sgRNA library was carried out
at ~ 80% confluency with 3.3 × 107 cells in T150 or T525
(triple layer) flasks, depending on cell size and surface area
required, in technical triplicates. Cells were transduced
with a predetermined viral amount that gives rise to ~
30% transduction, measured by BFP expression by cytom-
etry, to ensure approximately 1 viral particle entering each
cell based on a Poisson distribution model. Based on these
initial cell numbers and transduction efficiency, the cover-
age of the sgRNA library (i.e. the number of cells contain-
ing each sgRNA) in each replicate was 100×. Puromycin
selection commenced at day 4 to select for cells that had
successful lentiviral integration. Actual library transduc-
tion efficiency and puromycin selection was analysed
using flow cytometry before and after puromycin selec-
tion, respectively. A minimum number of 5.0 × 107 cells
were maintained at all times to ensure library representa-
tion was maintained. The cells were harvested 14 days
post transduction and dry pellets were stored at − 80 °C.
Extraction of genomic DNA, PCR amplification of
sgRNAs and Illumina sequencing of sgRNAs were carried
out as described previously [3, 6]. The number of reads
for each sgRNA was determined using a script developed
in-house.
Data pre-processing and availability
sgRNA counts from both Project Score and Project Achil-
les (downloaded from: https://depmap.org/ceres/) were
normalised assembling one batch per cell line, including
the read counts from the matching library plasmid and all
final read counts replicates, with a median-ratio method
[30] to adjust for the effect of library sizes and read count
distributions, after filtering out sgRNAs with less than 30
reads in the plasmid. Depletions/enrichments for individ-
ual sgRNAs were quantified as log2 ratio between post
library-transfection read-counts and library plasmid
read-counts. Finally, sgRNAs were averaged across repli-
cates. This was performed executing the ccr.Normfold-
Changes function of the CRISPRcleanR R package.
Transcriptional and copy number data
Genome-wide substitute reads with fragments per kilo-
base of exon per million reads mapped (FPKM) for the
15 cell lines considered in this study were derived from
the dataset described in [31]. Genome-wide gene level
copy number data, derived from PicNic analysis of Affy-
metrix SNP6 segmentation data (EGAS00001000978) for
the cell lines in the Genomics of Drug Sensitivity 1000
(GDSC1000) cancer cell line panel [13], were down-
loaded from the GDSC data portal (dataset version: July
4th 2016), http://www.cancerRxgene.org. This dataset is
also available at http://ftp.sanger.ac.uk/pub/project/can-
cerrxgene/releases/release-6.0/Gene_level_CN.xlsx. For
each gene, the minimum copy number of any genomic
segment containing coding sequence was considered.
(See figure on previous page.)
Fig. 6 CRISPRcleanR enables detection of cancer gene dependencies. a Detection of EGFR and PIK3CA dependencies at the level of targeting
sgRNAs in mutant cancer cell lines. Rank position of sgRNAs targeting the indicated genes before (top) and after (bottom) CRISPRcleanR
correction. FE and non-essential genes are shown for comparison. b A CN-amplified region of chromosome 8 in HT-29 cell line including MYC
and 3 surrounding up-streaming/down-streaming genes. Expanded view of sgRNAs targeting MYC and its surrounding genes, with each gene
identified by a different colour. The heatmaps (first 7 columns) show ranked positions of the sgRNAs targeting the 7 considered genes (blue bars)
before (top heatmap) and after (bottom heatmap) CRISPRcleanR correction. The last two columns show rank positions for the sgRNAs targeting
FE genes (second last column) and non-essential genes (last column). c Same as for B but considering a region on chromosome 16 in the NCI-
H2170 cell line, including ERBB2 and four flanking upstreaming/downstreaming genes and CDK12
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Additionally, gene level Gistic [25] scores obtained by
processing Affymetrix SNP array data in the Cancer Cell
Line Encyclopaedia [32] repository were downloaded
from cBioPortal [33] (http://www.cbioportal.org/
study?id=cellline_ccle_broad#summary).
Analysis of gene-independent responses in cancer cell lines
For each cell line, segments of equal CN were identified by
using CN data from the GDSC data portal [13, 14] (as de-
tailed below), and assigned a mean-logFC value by averaging
across all of the sgRNAs targeting a segment. A CN bias
starting point was computed for each cell line as the copy
number value n > 2 such that statistically significant differ-
ences, as quantified by a Welch’s t-test, were observable be-
tween the mean-logFCs of segments of n CNs and those of
segments of 2 CN. A CN bias critical point was computed
for each cell line as follows. For each CN value n = 3, …,
m-1 (with m =maximal segment CN value observed in the
cell line under consideration), two univariate linear models
were fitted, considering segment CN values as observations
of the independent variable and the corresponding average
segment mean-logFCs as those of the dependent one. The
first model P(n) was fitted using CN values in {2, …, n} and
corresponding average segment mean-logFCs, while the
second one L(n) was fitted using CN values in {n + 1, ..., m}
and corresponding average segment mean-logFCs. The bias
critical point was then defined as the value n providing the
large absolute difference between the slopes of the corre-
sponding fitted models P(n) and L(n).
Calling significantly depleted sgRNAs and genes based on
log fold-changes
All sgRNA were ranked by average logFCs derived from
screening an individual cell line. This ranked list was
used to classify sgRNAs targeting genes from two
gold-standard reference sets of FE and non-essential
genes [15, 21]: from now the essential-sgRNAs (E) and
the non-essential-sgRNAs (N). For each rank position k,
a set of predictions P(k) = {s ∈ E ∪N : ϱ(s) ≤ k}, with ϱ(s)
indicating the rank position of s, was assembled and
corresponding Precision (or Positive Predicted Value,
PPV(k)) was computed as:
PPV kð Þ ¼ P kð Þ∩Ej j= P kð Þj j:
Subsequently the largest rank position k∗ corresponding
to a 0.95 Precision (equivalent to a False Discovery Rate
(FDR) = 0.05) was determined as.
k ¼ maxNk¼1 1−PPV kð Þ ≤ 0:05f g:
Finally, a 5% FDR logFCs threshold F∗ was determined
as the logFCs of the sgRNAs s such that k(s) = k∗, and all
the sgRNAs of the entire library with a logFC < F∗ were
considered significantly depleted at this FDR level.
To call depletion significance at a gene level, the same
procedure was followed but averaging logFCs of sgRNAs
targeting the same gene prior to the analysis, and con-
sidering ranks and positive/negative sets of genes instead
of sgRNAs.
For the follow up analyses on the effect of correcting
sgRNA treatment counts (computed as detailed below) we
used the test function of the MAGeCK python package,
indicating none as the value of the parameter specifying
the normalisation method to use prior to the analysis, as a
median-ratio normalisation was already applied to the
analysed count files prior CRISPRcleanR correction.
Receiver operating characteristic analyses
Across the different analyses, standard ROC indicators
were computed considering as prediction sets signifi-
cantly depleted sgRNAs (or genes) at a fixed level of 5%
FDR (computed as detailed in the previous section or
output by the MAGeCK tool), or genome-wide profiles
of essentiality (as ranked lists of sgRNA logFCs, in some
instances averaged on a per gene basis) to compute over-
all indicator curves, and using different positive/negative
control sets (detailed below). To this aim, we made use
of functions included in the pROC R package [34].
For the positive controls, sets of a priori essential genes
were assembled by downloading relevant gene signatures
from the MSigDB [16] (Additional file 1: Table S6). A list
of ribosomal protein gene was derived from [17]. The
consensual signatures resulting from this curation are
available as individual data objects in the CRISPRcleanR R
package.
Segmentation analysis and logFC correction
Genome-wide essentiality profiles in the form of lists of
sgRNAs logFC were sorted according to the genomic
coordinates of the individual sgRNAs (library annotation
and coordinates derived from [6]) using the function
ccr.logFCs2chromPos of the CRISPRcleanR R package.
Then, a circular binary segmentation algorithm [18, 19]
was applied using the ccr.GWclean function of the
CRISPRcleanR R package, with a significance threshold to
accept change-points p = 0.01, 10,000 permutations for
p-value computation, a minimal number of 2 markers per
region, and making use of the function segment from the
DNAcopy R package [20] with other parameters set to
default values.
Subsequently, sgRNA included in a segment had their
logFCs mean-centered (across that segment) if collectively
targeting at least n = 3 different genes, without pre-filtering
any essential gene (differently from the sliding window
approach used in [9]). This correction assumes that the true
signal of loss/gain-of-fitness effect exerted by knocking-out
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a CN amplified gene sums up to a possible
gene-independent impact on cellular fitness induced by
targeting with CRISPR-Cas9 the chromosomal segment
where that gene resides. By subtracting the logFCs mean to
the sgRNA in the same detected biased segment, the
gene-independent effect is flattened letting true fitness
signals emerge. The possibility of using a median-based
centering as a more robust alternative when the data is par-
ticularly noisy and/or many outliers are present (verifiable
through a preliminary inspection of the uncorrected
logFCs), for example due to dysfunctional or especially
toxic sgRNAs, is also present in the implementation of
CRISPRcleanR.
The minimal number n of targeted genes that a biased
segment should contain in order to be corrected was
adaptively determined by executing different trials of
segments’ detection and correction varying n ∈ {2, 3, 5, 10}
and excluding/not-excluding from the analysis sets of a
priori known essential genes assembled from MSigDB (as
detailed in the previous section), collectively the filter set.
Removing the filter set from a reference set of the FE
genes yielded a test set. Areas under the recall curve
(AURCs) were then computed evaluating the classification
performances using as positive controls the test set, CN
amplified genes, and CN amplified non-expressed genes
(determined for each cell line) were then computed, across
each trial using targeting sgRNAs’ logFCs before/after
correction. For each of the positive control sets, reduction
of recall (recall) were computed by comparing AURCs
obtained before/after CRISPRcleanR correction.
Results showed that n = 3 provided the largest reduc-
tion of recall (Additional file 2: Figure S5) of CN ampli-
fied and CN amplified non-expressed genes, and the
lowest reduction of recall of the test set. Most import-
antly, this was observed invariantly with respect to
removing/not-removing the filter set prior the analysis.
As a conclusion, all the corrections presented in this
manuscript were executed with this setting (n = 3 and
without pre-filtering any gene). CRISPRcleanR package
uses these settings by default, although offering to the
user the possibility of changing them.
Comparison of results across different libraries
Data from the mutagenesis of the HT-29 cell lines with
the Brunello and Whitehead libraries were downloaded
from the supplementary material of [24] and processed
as described in the section Data pre-processing and
availability. Correction outcomes were computed as de-
tailed in Receiver Operating Characteristic analyses.
Correction of sgRNA counts
We derived CRISPRcleanR corrected treatment count
values for individual experiment technical replicates
from the corresponding CRISPRcleanR corrected
sgRNAs’ logFCs. To this aim, for each individual sgRNA,
we first compute a CRISPRcleanR corrected treatment
count averaged-across-replicate (first 7 formulas below),
then we computed corrected treatment counts for indi-
vidual replicates from this averaged value partitioning it
across replicates proportionally to original (uncorrected)
count values.
Formally, for each individual single guide RNA, a cor-
rected treatment count ti was computed observing that:
N ¼ E log2
ti
c
 
with N =CRISPRcleanR corrected logFCs for the sgRNA
under consideration, i = 1, …, n, where n = number of
treatment replicates, and c = counts of the sgRNA in the
plasmid, and E indicates the mean function.
This implies
N ¼
Pn
i¼1 log2 ti=cð Þ
n
⟹nN ¼
Xn
i¼1
log2ti−
Xn
i¼1
log2c ¼
Xn
i¼1
log2ti−n log2c
⟹nN þ n log2c ¼
Xn
i¼1
log2ti:
Assuming, for simplicity that all the ti are the same
(= t),
nN þ n log2c ¼ n log2ti
⟹2Nþ log2c ¼ t
⟹t ¼ c2N ¼ E tð Þ:
To derive the corrected counts for the individual repli-
cates (which are obviously different from each other) from
their mean, we keep constant the proportions seen in the
uncorrected counts with respect to the sum of the counts
across replicates:
E tð Þ ¼
Pn
i¼1ti
n
⟹nE tð Þ ¼
Xn
i¼1
ti
⟹ti ¼ n E tð Þ t

i
T 
¼ nc2N t

i
T 
where ti is the count of the sgRNA under consideration
before correction in the i-th replicate and T∗ is their over-
all sum across replicates.
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CRISPRcleanR performances with respect to data quality
Cell lines from Project Achilles were grouped into 10
equidistant bins based on the quality of the corresponding
profiles of gene essentiality, in increasing order. Data qual-
ity was quantified by the recall at 5% FDR for MSigDB
[16] essential genes based on uncorrected fold-change
rank positions. For each bin a variation of Recall pre/
post-CRISPRcleanR correction was quantified, for 9 pre-
defined gene sets, encompassing prior known essential/
non-essential genes, copy number amplified genes and
non expressed genes, as detailed in the previous sections.
Evaluation of CRISPRcleanR correction on fitness gene
calling
Gain/loss-of-fitness effect false discovery rate (FDR)
scores were obtained by applying MAGeCK before/after
CRISPRcleanR correction on the sgRNA counts from
Project Score and Project Achilles. Percentages of atten-
uated fitness genes were computed as the ratio of genes
with a significant gain/loss-of-fitness FDR (fitness genes),
from the analysis of the uncorrected sgRNAs but not
from the analysis of the corrected ones, with respect to
the whole set of screened genes or the set of fitness
genes detected in the uncorrected data, respectively.
Percentages of distorted fitness genes were computed as
the ratio of fitness genes detected in the uncorrected
data which where still detected as fitness genes in the
corrected data but with an opposite effect. Similar ratios
were computed for attenuated/distorted loss-of-fitness
and gain-of-fitness genes individually. The loss-of-fitness
genes attenuated post-correction were further parti-
tioned sequentially into the following disjoint sets across
cell lines: non-expressed (with an FPKM < 0.05), copy
number amplified (with a Gistic score > 1 or a PicNic
copy number value > 2), prior-known non-essential (ac-
cording to [15]), mild-phenotype (with a depletion logFC
in the uncorrected data, averaged across targeting
sgRNAs, falling over the 4th quartile of the logFCs of all
the loss-of-fitness genes). Only cell lines with good qual-
ity data (recall for essential genes from [15] at 5% FDR >
0.5) and all data type (GISTIC and PicNic copy number,
and basal expression FPKMs) available were included in
this analysis.
Retention of cancer driver gene dependencies following
CRISPRcleanR correction
We performed a systematic unbiased case-by-case probing
of putative oncogene addictions, by evaluating how
corresponding dependencies are detected prior/post
CRISPRcleanR correction, using data from Project Score
and Project Achilles. From a list of 64 high confidence
oncogenes [27], we considered those harbouring a cancer
driver event (CDE), i.e. a cancer driver somatic mutation
or a CN amplification as defined in [13], in at least one
cell line of the two considered panels. For the Project
Achilles, the analysis was restricted to 239 cell lines with
genomic data available in [13]. The considered CN amplifi-
cations were at the chromosomal segment level and many
of them included more than one oncogene. For each CDE
observed in a given cell line, we then compared the loss/
gain-of-fitness effect of the involved oncogene(s) observed
prior/post-CRISPRcleanR in that cell line, quantified as
MAGeCK FDRs. For Project Score, this resulted into 57
tested dependencies involving 29 CDEs (9 mutations and
20 CNAs encompassing multiple genes on the same seg-
ments). For Project Achilles, this resulted into 507 tested
dependencies: 37 CDFEs (26 mutations and 11 CNAs
encompassing multiple genes on the same segments).
Additional files
Additional file 1: Table S1. Project Score cell lines included in the study
with annotations and screening description. Table S2. Quantification of
copy number-associated bias before and after CRISPRcleanR correction.
Table S3. Recall reduction following CRISPRcleanR correction across control
gene-sets and cell lines. Table S4. Recall reduction post CRISPRcleanR
correction across controls (mean-variance modeling). Table S5. Cancer
driver gene dependencies following CRISPRcleanR correction. Table S6. List
of gene signatures downloaded from MSigDB and used as positive controls.
(ZIP 6330 kb)
Additional file 2: Figure S1. CRISPR-KO screening data quality assessment.
(A) Average correlation between sgRNAs read-count replicates across cell lines.
(B) Receiver operating characteristic (ROC) curve obtained from classifying
fitness essential (FE) and non-essential genes based on the average logFC
of their targeting sgRNAs. An example cell line OVCAR-8 is shown. (C) Area
under the ROC (AUROC) curve obtained for cell lines from classifying FE and
non-essential genes based on the average logFC of their targeting sgRNAs. (D)
Recall for sets of a priori known essential genes from MSigDB and from literature
when classifying FE and non-essential genes across cell lines (5% FDR). Each
circle represents a cell line and coloured by tissue type. Box and whisker plots
show median, inter-quartile ranges and 95% confidence intervals. (E) Genes
ranked based on the average logFC of targeting sgRNAs for OVCAR-8 and
enrichment of genes belonging to predefined sets of a priori known essential
genes from MSigDB, at an FDR equal to 5% when classifying FE (second last
column) and non-essential genes (last column). Blue numbers at the bottom
indicate the classification true positive rate (recall). Figure S2. Assessment of
copy number bias before and after CRISPRcleanR correction across cell lines.
sgRNA logFC values before and after CRISPRcleanR for eight cell lines are shown
classified based on copy number (amplified or deleted) and expression status.
Copy number segments were identified using Genomics of Drug Sensitivity
in Cancer (GDSC) and Cell Line Encyclopedia (CCLE) datasets. Box and whisker
plots show median, inter-quartile ranges and 95% confidence intervals. Asterisks
indicate significant associations between sgRNA LogFC values (Welchs t-test,
p< 0,005) and their different effect sizes accounting for the standard deviation
(Cohen’s D value), compared to the whole sgRNA library. Figure S3. CN-
associated effect on sgRNA logFC values in highly biased cell lines. For 3 cell
lines, recall curves of non-essential genes, fitness essential genes, copy number
(CN) amplified and CN amplified non-expressed genes obtained when
classifying genes based on the average logFC values of their targeting
sgRNAs. Figure S4. Assessment of CN-associated bias across all cell lines.
LogFC values of sgRNAs averaged within segments of equal copy number
(CN). One plot per cell line, with CN values at which a significant differences
(Welchs t-test, p < 0.05) with respect to the logFCs corresponding to CN = 2
are initially observed (bias starting point) and start to significantly increase
continuously (bias critical point). CN-associated bias is shown for all sgRNA,
when excluding FE genes and histones, and for non-expressed genes only.
Box and whisker plots show median, inter-quartile ranges and 95% confidence
intervals. Figure S5. CRISPRcleanR correction varying the minimal number of
genes required and the effect of fitness essential genes. Recall reduction of (A)
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amplified or (B) amplified not-expressed genes versus that of fitness essential
and other prior known essential genes, when comparing CRISPRcleanR
correction varying the minimal number of genes to be targeted by sgRNA in
a biased segment (default parameter is n = 3). Similar results were observed
when performing the analysis including or excluding known essential genes.
Figure S6. CRISPRcleanR performances across 342 cell lines from an
independent dataset. Recall at 5% FDR of predefined sets of genes based
on their uncorrected or corrected logFCs (coordinates on the two axis)
averaged across targeting sgRNAs for 342 cell lines from the Project Achilles.
Figure S7. CRISPRcleanR performances in relation to data quality. The
impact of data quality on recall at 5% false discovery rate (FDR) assessed
following CRISPRcleanR correction for predefined set of genes. Project
Achilles data (n = 342 cell lines) was binned based on the quality of
uncorrected essentiality profile. This is obtained by measuring the recall at
5% FDR for predefined essential genes (from the Molecular Signature
Database) and grouping the cell lines in 10 equidistant bins (1 lowest quality
and 10 highest quality) when sorting them based on this value. Recall
increment for fitness essential genes was greatest for the lower quality data,
indicating that CRISPRcleanR can improve true signal of gene depletion in
low quality data. Figure S8. Minimal impact of CRISPRcleanR on loss/gain-
of-fitness effects. (A) The percentage of genes where the significance of their
fitness effect (gain- or loss-of-fitness) is altered after CRISPRcleanR for Project
Score and Project Achilles data. The upper row shows correction effects for
all screened genes and the lower row for the subset of genes with a
significant effect in the uncorrected data. Each dot is a separate cell line.
Blue dots indicate the percentage of genes where significance is lost or
gained post correction. Green dots indicate the percentage of genes where
the fitness effect is distorted and the effect is opposite in the uncorrected
data. (B) The majority of the loss-of-fitness genes impacted by correction are
putative false positive effects affecting genes which are either not-expressed
(FPKM < 0.5), amplified, known non-essential, or exhibit a mild phenotype
in the screening data. (C) Summary of overall impact of CRISPRcleanR on
fitness effects following correction when considering data for all cell lines.
The colors reflect the percentage of genes with a loss-of-fitness, no
phenotype or gain-of-fitness effect which are retained in the corrected data.
Figure S9. CRISPRcleanR retains cancer driver gene dependencies in Project
Score and Achilles data. (A) Each circle represents a tested cancer driver
gene dependency (mutation or amplification of a copy number segment)
and the statistical significance using MaGeCK before (x-axis) and after (y-axis)
CRISPRcleanR correction, across the two screens. Plots in the first row show
depletion FDR values pre/post-correction, whereas those in the second row
show depletion FDR values pre-correction and enrichment FDR values post-
correction. (B) Details of the tested genetic dependencies and whether they
are shared before and after CRISPRcleanR correction at two different thresh-
olds of statistical significance (5 and 10% FDR, respectively for 1st and 2nd
row of plots). The third row indicates the type of alteration involving the
cancer driver genes under consideration and the total number of cell lines
with an alteration. (ZIP 191 kb)
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